Pharmacological inhibition of RORC2 enhances human Th17‐Treg stability and function
Dominic A. Boardman(University of British Columbia), Megan K. Levings(University of British Columbia), TG Murali Dhar(Bristol-Myers Squibb (United States)), Rosa V. Garcia(University of British Columbia), Qihong Zhao(Bristol-Myers Squibb (United States)), Brian Bressler(University of British Columbia), Sabine Ivison(University of British Columbia)
Cited by 23
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells
|The Journal of Immunology|2001|591
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
|European Journal of Immunology|2021|506